Skip to main content

JAK/TYK2

    Day 4 was a half day closeout to the EULAR 2023 Congress. For me the big presentations were the late breaking abstracts, although there were other review and abstract sessions for those remaining.…
    An update on JAK inhibitors and cardiovascular risks

    Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments
    10 months 1 week ago
    An update on JAK inhibitors and cardiovascular risks Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments on JAK/TYK2 inhibitors. https://t.co/VovWE2OuXW https://t.co/QXKZLh5RuK
    EULAR 2023 Day 4 Recap
    Upadacitinib in SLE
    Daily Recap: Day Three EULAR 2023
    Should JAKs be ‘Tyk’ed off?
    RT @bella_mehta: Abstracts talking about #RA and JAKs and Biologic comparisons
    Huge number of pts to analyze this aftrr
    10 months 1 week ago
    Abstracts talking about #RA and JAKs and Biologic comparisons Huge number of pts to analyze this aftrr the initial NEJM study. Abstract summary pics below @RheumNow https://t.co/jl5S4fLq19